To keep up with the rapidly evolving R&D needs of the pharma and specialty chemicals industry, CDMOs and CROs are increasingly managing contractual work in a variety of modalities, providing everything from full-time employee service agreements to comprehensive development programs. Speaking of which, Innovassynth Technologies is consciously and discreetly carving a niche for itself in the CDMO & CRO industry.
Innovassynth is on a rapid transformational journey, and it is making continuous progress to build a new brand identity based on three timeless principles that are the very cornerstone of its success - Innovation, Integrity, and Ingenuity.
To fuel its strategic priorities, it has recently inaugurated a new 24000 sq ft state-of-the-art research facility and corporate office in Pune, Innovassynth is also expanding its capacity in the picturesque 61-acre manufacturing facility at Khopoli, near Mumbai area.
Innovassynth recognizes the power and significance of the medium, or 'the chemicals,' it engages with. Hence, the organization takes effort to ensure this medium’s potential benefits are channeled constructively.
The organization has teamed with a Global Consulting firm to apply precisely planned protocols that guarantee the safety of people, materials, and the environment at every stage from procurement to final delivery. The 'Parivartan for Suraksha' project, which aspires to have zero
incidents relating to safety and the environment across the board, was successfully introduced by Innovassynth in collaboration with this consultant.
The core competence of the firm lies in the custom synthesis of Amidites, protected Nucleosides, reagents for Nucleoside synthesis, development and scale-up of Organometallic Ligands & donors, Specialty bulk intermediates & process intensification services. Innovassynth’s manufacturing abilities are boosted by 10 multipurpose plants that can undertake and deliver Kg to MT level manufacturing projects. The company has a proven track record of successful and safe handling of air and moisture-sensitive chemistry, Hydrogenation, Cryogenic, and various hazardous gasses.
Further, custom development and manufacturing at scale offerings backed by transparent supply chains, and documentation support have made Innovassynth a one-stop solution from development to manufacturing-related requirements. Their core strengths like diversified offerings for Nucleoside chemistry, fit-for-purpose Specialty Chemicals Service Offerings, and their large-scale contract manufacturing footprints are set to be leveraged to deliver a very potent competitive edge going forward. Yet the biggest asset for Innovassynth which can help fuel their growth in future, is the land parcel available at their disposal that can be readily utilized to set-up a state-of-the-art manufacturing infrastructure.
-
As we pursue our aspirations and explore newer growth avenues, environment, health & safety (ehs) will continue to remain key priorities for our employees
Dr. Hardik Joshipura, MD & CEO
Robust Roadmap Ahead
Going forward, "we expect our investment in the new R&D facility at Pune to leverage our research capabilities in expanding our presence in the life sciences area by offering Full Time Equivalent (FTE) & Fee For Services (FFS). This will be further fueled by establishing a cGMP manufacturing facility at Khopoli in the mid-term horizon", highlights Dr. Hardik Joshipura, MD & CEO at Innovassynth. Further, the company believes in leveraging latest technologies and methodologies to bring in the needed innovation and stay relevant with the changing market dynamics. As we pursue our aspirations and explore newer growth avenues, Environment, Health & Safety (EHS) will continue to remain key priorities for our employees", he concludes.
